About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:3693614
Allelic
Composition
Gata3tm1Gsv/Gata3+
Genetic
Background
involves: 129S7/SvEvBrd * C57BL/6 * FVB/N
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gata3tm1Gsv mutation (0 available); any Gata3 mutation (32 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
hearing/vestibular/ear
• at 2, 9, and 15 months, heterozygotes show an earlier and greater loss of OHCs, IHCs, and nerve fibers than wild-type mice
• HC loss initiates at the apex and ultimately progresses into the sensory epithelia in middle cochlear turns
• by 9 months, heterozygotes show significant IHC loss at both the apical and basal turns of the cochlea
• at 1 month, heterozygotes show partial but progressive loss of OHCs and, to a lesser extent, of their auditory nerve fibers at the apex
• at 2 months, only remnants of the three OHC rows are detected
• by 9 months, all mutant OHCs are lost, while wild-type OHCs are only affected at the base of the cochlea
• at 2, 9, and 15 months, heterozygotes show an earlier and greater loss of pillar cells than wild-type mice
• by 15 months, pillar cells are almost completely lost
• by 15 months, supporting cells of the organ of Corti are almost completely degenerated
• by 15 months, the heterozygous organ of Corti is almost completely degenerated
• at 1-19 months, alert heterozygotes exhibit a significant ABR threshold elevation of ~30 dB at virtually all frequencies (4, 8, 16 and 32 kHz) and all ages tested
• at stimulus levels of 80 SPL or higher that are at least 30 dB above threshold levels, heterozygotes show no differences in ABR peak I-V latencies, corrected for tonotopic effects, relative to wild-type mice
• interpeak latencies are shorterned by ~0.3 ms during the first 100 days in both wild-type and mutant mice
• neither physiological nor morphological abnormalities are detected in the brainstem, cerebral cortex, the outer or the middle ear
• at 1-19 months, heterozygotes display sensorineural hearing loss of peripheral origin, similar to HDR patients

nervous system
• at 2, 9, and 15 months, heterozygotes show an earlier and greater loss of OHCs, IHCs, and nerve fibers than wild-type mice
• HC loss initiates at the apex and ultimately progresses into the sensory epithelia in middle cochlear turns
• by 9 months, heterozygotes show significant IHC loss at both the apical and basal turns of the cochlea
• at 1 month, heterozygotes show partial but progressive loss of OHCs and, to a lesser extent, of their auditory nerve fibers at the apex
• at 2 months, only remnants of the three OHC rows are detected
• by 9 months, all mutant OHCs are lost, while wild-type OHCs are only affected at the base of the cochlea

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
hypoparathyroidism-deafness-renal disease syndrome DOID:0060878 OMIM:146255
J:116235


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory